Abstract
It was reported that mast cell degranulation is inversely related to the enzymatic activity of M2-type pyruvate kinase (M2PK). This study shows that activation of high-affinity IgE receptor (FcεRI) evokes a sequential dual regulation of M2PK, i.e., an immediate decrement followed by slow phase increment of enzymatic activities. Changes in the activities of M2PK and mast cell degranulation showed similar time course after antigenic stimulation of FcεRI. The immediate inhibition of M2PK involved tyrosine phosphorylation, and subsequently led to a cellular accumulation of glycolytic intermediates, including fructose 1,6-biphosphate (FBP), a feedforward activator of M2PK. As the cellular levels of FBP were increased, both the enzymatic acitivity of M2PK and mast cell degranulation slowly returned to near basal levels. A-Raf, when exogenously introduced into RBL-2H3 cells, phosphorylated M2PK on the serine residues, elevated enzyme activities of M2PK, and resulted in the inhibition of degranulation. These results suggest that dual regulation of M2PK which involves the phosphorylation of M2PK and accumulation of a feedforward activator of M2PK plays important roles in the control of mast cell degranulation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bali, M., and S.R. Thomas. 2001. A modelling study of feedforward activation in human erythrocyte glycolysis. C R Acad Sci III 324(3): 185–199.
Blank, U., C. Ra, L. Miller, K. White, H. Metzger, and J.P. Kinet. 1989. Complete structure and expression in transfected cells of high affinity IgE receptor. Nature 337(6203): 187–189.
Buchtova, L., and O. Cech. 1982. [Changes in certain enzymes of anaerobic glycolysis and pentose cycle in atopic eczema (author’s transl)]. Cesk Dermatology 57(1): 23–26.
Cardenas, J.M. 1982. Pyruvate kinase from bovine muscle and liver. Methods in Enzymology 90: 140–149.
Chakravarty, N. 1967. Inhibition of histamine release from rat mast cells by 2-deoxyglucose. Acta Pharmacol Toxicol (Copenh) 25(Suppl): 35.
Christofk, H.R., M.G. Vander Heiden, N. Wu, J.M. Asara, and L.C. Cantley. 2008. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452(7184): 181–186.
Eigenbrodt, E., M. Reinacher, U. Scheefers-Borchel, H. Scheefers, and R. Friis. 1992. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Critical Reviews in Oncogenesis 3(1–2): 91–115.
Ibsen, K.H. 1977. Interrelationships and functions of the pyruvate kinase isozymes and their variant forms: A review. Cancer Research 37(2): 341–353.
Imamura, K., and T. Tanaka. 1982. Pyruvate kinase isozymes from rat. Methods in Enzymology 90: 150–165.
Izumi, Y., A.M. Benz, H. Katsuki, M. Matsukawa, D.B. Clifford, and C.F. Zorumski. 2003. Effects of fructose-1,6-bisphosphate on morphological and functional neuronal integrity in rat hippocampal slices during energy deprivation. Neuroscience 116(2): 465–475.
Le Mellay, V., R. Houben, J. Troppmair, C. Hagemann, S. Mazurek, U. Frey, et al. 2002. Regulation of glycolysis by Raf protein serine/threonine kinases. Advances in Enzyme Regulation 42: 317–332.
Mazurek, S., A. Michel, and E. Eigenbrodt. 1997. Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates. Journal of Biological Chemistry 272(8): 4941–4952.
Miklaszewska, M., Z. Kobierzynska-Golab, F. Wasik, and G. Szybejko-Machaj. 1989. Activity of pyruvate kinase and glucose-6-phosphate dehydrogenase in polymorphonuclear granulocytes of patients with atopic dermatitis in the active stage and in remission. Przegl Dermatol 76(5–6): 381–385.
Nadler, M.J., S.A. Matthews, H. Turner, and J.P. Kinet. 2000. Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: Coupling form to function. Advances in Immunology 76: 325–355.
Noguchi, T., H. Inoue, and T. Tanaka. 1986. The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. Journal of Biological Chemistry 261(29): 13807–13812.
Oak, M.H., H. Cheong, and K.M. Kim. 1999. Activation of Fc epsilon RI inhibits the pyruvate kinase through direct interaction with the gamma-chain. International Archives of Allergy and Immunology 119(2): 95–100.
Okazaki, T., A. Okazaki, R.E. Reisman, and C.E. Arbesman. 1975. Glycogenolysis and control of anaphylactic histamine release by cyclic adenosine monophosphate-related agents. II. Modification of histamine release by glycogenolytic metabolites. Journal of Allergy and Clinical Immunology 56(4): 253–261.
Pemberton, A.D., J.K. Brown, S.H. Wright, P.A. Knight, and H.R. Miller. 2006. The proteome of mouse mucosal mast cell homologues: The role of transforming growth factor beta1. Proteomics 6(2): 623–631.
Ryu, H., J.K. Walker, S. Kim, N. Koo, L.S. Barak, T. Noguchi, et al. 2008. Regulation of M2-type pyruvate kinase mediated by the high-affinity IgE receptors is required for mast cell degranulation. British Journal of Pharmacology 154(5): 1035–1046.
Acknowledgments
This study was financially supported by the Ministry of Knowledge Economy (MKE), Korea Institute for Advancement of Technology (KIAT) through the Inter-ER Cooperation Project (R0002019).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zheng, M., Cho, DI., Le, H.T. et al. Dual regulation of mast cell degranulation through IgE receptor-mediated modulation of M2-type pyruvate kinase. Arch. Pharm. Res. 37, 1177–1182 (2014). https://doi.org/10.1007/s12272-014-0341-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-014-0341-5